Results for SARS-CoV-2

Add to feed Create your own feed

Latest

New Article online now at Cell: SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

While the amount of antibodies generated varies widely in patients who have recovered from coronavirus, most people generate at least some antibodies which are intrinsically capable of neutralizing the SARS-CoV-2 virus. #covid19  #coronavirus 

Correspondence: More on Neurologic Features in Severe SARS-CoV-2 Infection #COVID19  #SARSCoV2 

Of 116 SARS-CoV-2-+ specimens in @StanfordMed  patients tested in March 2020, 21% were positive for 1 or more additional pathogens, mainly rhinovirus/enterovirus, RSV, and non–SARS-CoV-2 Coronaviridae#COVID19  #Coronavirus 

Researchers still don’t know if antibodies that recognize SARS-CoV-2 prevent people from catching the virus a second time—or, if they do, how long that protection might last.

Towards computer-aided severity assessment: training and validation of deep neural networks for geographic extent and opacity extent scoring of chest X-rays for SARS-CoV-2 lung disease severity

Loading
Loading

Most relevant

SARS-CoV-2 was detected in three cats after they were cohoused with cats that had been experimentally inoculated with the virus. Cats may be a silent intermediate host of SARS-CoV-2. #COVID19  #SARSCoV2 

NEW—Paediatricians describe a cluster of 8 children believed to represent a "new phenomenon affecting previously asymptomatic children w/ SARS-CoV-2 infection manifesting as a hyperinflammatory syndrome with multiorgan involvement similar to Kawasaki disease shock syndrome" (1/2)

tweet picture

More than 90 vaccines are being developed against SARS-CoV-2 across the world. At least six groups have begun injecting formulations into volunteers in safety trials. Here is a graphical guide explaining each vaccine design. #COVID19 

National Institute of Virology, Pune has successfully developed the 1st indigenous anti-SARS-CoV-2 human IgG ELISA test kit for antibody detection of #COVID19  . This robust test will play a critical role in surveillance of proportion of population exposed to #SARSCoV2  infection

tweet picture

More than 90 vaccines are being developed against SARS-CoV-2 across the world. At least six groups have begun injecting formulations into volunteers in safety trials. Here is a graphical guide explaining each vaccine design. #COVID19 

In a first, Indian scientists have revealed a microscopy image of SARS-CoV-2 virus (COVID19). Scientists took the throat swab sample from first laboratory-confirmed COVID19 case in India, reported on Jan 30 in Kerala. The findings are published in the latest edition of the IJMR.

tweet picture

University of Pittsburgh School of Medicine announced that the vaccine, when tested in mice, produces antibodies specific to the coronavirus SARS-CoV-2 that could be enough to fight off the virus.

I wrote about the new coronavirus itself--where it came from, why it's behaving in the way it's behaving, how it infects and kills, and what the summer might bring. It's early days, of course, but this serves as a rough preliminary portrait of SARS-CoV-2.

Some not-horrible news on SARS-CoV-2 for once: It's mutating slowly considering how many people it has infected, which suggests a vaccine would be lasting, like vaccines for measles or chickenpox, rather than temporary like vaccines for flu. @JoelAchenbach 

Quick tip on #COVID_19  terminology: *Coronavirus: family of viruses that cause, eg, common cold, MERS, SARS *Novel coronavirus: a newly discovered kind of coronavirus *COVID-19: the disease caused by the new coronavirus *SARS-CoV-2: official designation of virus causing COVID-19

Loading
Loading